AND ANOTHER ONE: Eli Lilly says next-generation weight loss drug clears crucial obesity trial. “The

AND ANOTHER ONE: Eli Lilly says next-generation weight loss drug clears crucial obesity trial. “The highest dose of retatrutide helped patients lose 28.3% of their weight — or 70.3 pounds — on average over 80 weeks.”